NEVRO CORP's ticker is NVRO and the CUSIP is 64157F103. A total of 201 filers reported holding NEVRO CORP in Q1 2022. The put-call ratio across all filers is 1.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $50,205,355 | +5.4% | 1,267,812 | +24.0% | 0.01% | -7.7% |
Q3 2022 | $47,638,854 | +6.3% | 1,022,293 | 0.0% | 0.01% | +8.3% |
Q2 2022 | $44,807,102 | +28.9% | 1,022,293 | +112.7% | 0.01% | +50.0% |
Q1 2022 | $34,757,241 | +20.2% | 480,537 | +34.7% | 0.01% | +33.3% |
Q4 2021 | $28,917,000 | +20.5% | 356,692 | +72.9% | 0.01% | +20.0% |
Q3 2021 | $24,005,000 | +59.8% | 206,267 | +127.7% | 0.01% | +66.7% |
Q2 2021 | $15,018,000 | -60.6% | 90,585 | -66.8% | 0.00% | -66.7% |
Q1 2021 | $38,111,000 | -31.1% | 273,200 | -14.5% | 0.01% | -30.8% |
Q4 2020 | $55,290,000 | +20.0% | 319,413 | -3.5% | 0.01% | +8.3% |
Q3 2020 | $46,094,000 | +13.6% | 330,896 | -2.6% | 0.01% | 0.0% |
Q2 2020 | $40,576,000 | +42.5% | 339,632 | +19.2% | 0.01% | +20.0% |
Q1 2020 | $28,476,000 | +2.4% | 284,820 | +20.4% | 0.01% | +25.0% |
Q4 2019 | $27,803,000 | +52.2% | 236,539 | +11.3% | 0.01% | +33.3% |
Q3 2019 | $18,272,000 | +32.6% | 212,548 | 0.0% | 0.01% | +50.0% |
Q2 2019 | $13,779,000 | -76.6% | 212,548 | -77.5% | 0.00% | -78.9% |
Q1 2019 | $58,951,000 | +60.7% | 943,051 | 0.0% | 0.02% | +35.7% |
Q4 2018 | $36,675,000 | +243.0% | 943,051 | +402.7% | 0.01% | +366.7% |
Q3 2018 | $10,693,000 | -6.6% | 187,609 | +30.9% | 0.00% | -25.0% |
Q2 2018 | $11,447,000 | +103963.6% | 143,365 | +110180.8% | 0.00% | – |
Q1 2018 | $11,000 | -99.1% | 130 | -99.3% | 0.00% | – |
Q4 2017 | $1,211,000 | -95.8% | 17,533 | -94.5% | 0.00% | -100.0% |
Q3 2017 | $28,857,000 | +14.2% | 317,533 | -6.5% | 0.01% | +10.0% |
Q2 2017 | $25,274,000 | +635.4% | 339,567 | +825.6% | 0.01% | +900.0% |
Q1 2017 | $3,437,000 | +358.3% | 36,685 | +255.2% | 0.00% | – |
Q4 2016 | $750,000 | -93.3% | 10,328 | -90.8% | 0.00% | -100.0% |
Q3 2016 | $11,136,000 | +116.1% | 111,688 | +59.9% | 0.01% | +150.0% |
Q2 2016 | $5,154,000 | +12.8% | 69,869 | -14.0% | 0.00% | 0.0% |
Q1 2016 | $4,570,000 | +56.2% | 81,230 | +87.4% | 0.00% | +100.0% |
Q4 2015 | $2,926,000 | +6260.9% | 43,344 | +4234.4% | 0.00% | – |
Q3 2015 | $46,000 | – | 1,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Iron Triangle Partners LP | 562,833 | $40,710,000 | 4.84% |
Altium Capital Management LP | 77,000 | $5,569,000 | 1.86% |
PFM Health Sciences, LP | 649,513 | $46,979,000 | 1.76% |
Rock Springs Capital Management LP | 721,500 | $52,186,000 | 1.31% |
Integral Health Asset Management, LLC | 50,000 | $3,617,000 | 0.94% |
Redmile Group, LLC | 411,017 | $29,729,000 | 0.93% |
K2 PRINCIPAL FUND, L.P. | 114,800 | $8,303,000 | 0.72% |
Connacht Asset Management LP | 18,762 | $1,357,000 | 0.70% |
Perceptive Advisors | 477,037 | $34,504,000 | 0.69% |
ArrowMark Colorado Holdings LLC | 855,439 | $61,874,000 | 0.54% |